News

SKIMS Expands Portfolio with SKKN Acquisition from Kim Kardashian

SKIMS Expands Portfolio with SKKN Acquisition from Kim Kardashian

SKIMS Further Innovates with the Acquisition of SKKN by Kim

SKIMS, co-founded by Kim Kardashian and Jens Grede, has made a significant move by acquiring SKKN by Kim from Kim Kardashian and Coty. This acquisition is a transformative step that aligns Kardashian's beauty ventures under the SKIMS umbrella, marking SKIMS's expansion beyond its apparel roots.

A New Era for Beauty and Lifestyle

With the acquisition of SKKN, SKIMS will incorporate Kardashian's extensive experience in the beauty space, including her notable work in cosmetics, skincare, and fragrance. This enhances SKIMS's portfolio, making it a powerhouse in the lifestyle and beauty industries.

Kardashian's Impact on Beauty

Kardashian's legacy in beauty began with the launch of KKW Beauty in 2017, revolutionizing makeup with her innovative contouring techniques. Her influence grew with the success of KKW Fragrance, which garnered 'Fragrance of the Year' at the FiFi Awards. This acquisition not only consolidates her impact but also sets the stage for SKIMS to innovate within beauty.

Streamlined Vision Under SKIMS

As Kim Kardashian stated, her mission has always been to create products that connect with consumers. With the integration of SKKN by Kim, there is an opportunity for a unified vision that extends from shapewear to skincare. Such cohesion reinforces SKIMS's commitment to empowering individuals through their choices.

How the Acquisition Changes SKIMS' Trajectory

According to Jens Grede, CEO and Co-Founder of SKIMS, this isn’t merely about growth. It's an assertion of SKIMS's strength as a brand, allowing it to venture into beauty with authority and credibility. The anticipated launch in 2026 signifies a new chapter for SKIMS.

Future Plans and Expected Launch

The integration of beauty, skincare, and fragrance marks a groundbreaking evolution for SKIMS. With plans to launch these new categories in 2026, it aims to redefine standards in beauty just as it has with apparel. Utilizing Kardashian’s proven track record, SKIMS seeks to disrupt the beauty market by providing innovative solutions that resonate with consumers globally.

About SKIMS

Founded in 2019, SKIMS is dedicated to redefining the standards of women’s underwear and shapewear, setting new benchmarks for inclusivity and innovation. The brand offers a variety of products, focusing on solutions that cater to all body types. By emphasizing technical design, from shapewear that enhances curves to elastic underwear, SKIMS is committed to pushing the industry forward. Customers can explore these innovative products directly at SKIMS.com and through established retail locations.

Frequently Asked Questions

What is the significance of SKIMS acquiring SKKN by Kim?

The acquisition allows SKIMS to expand into beauty, integrating Kardashian's expertise, which enhances their brand power and market reach.

When are the new SKIMS beauty products expected to launch?

New beauty products under the SKIMS brand are anticipated to launch in 2026.

How has Kim Kardashian influenced the beauty industry?

Kardashian's innovations have sparked new trends, including the contouring makeup craze, and have gained prestigious awards like 'Fragrance of the Year.'

What types of products will SKIMS offer in the beauty category?

SKIMS plans to offer a range of products including skincare, cosmetics, and fragrances, aiming to create a cohesive brand experience.

Where can I find SKIMS products?

SKIMS products are available online at SKIMS.com and in select retail locations worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

SAP Launches Sovereign Cloud Solution in Canada for Businesses

Updated Category News Views 365

SAP Enhances Data Security with New Cloud Solutions SAP SE shares are experiencing a positive trend in premarket trading. Recently, SAP Canada introduced its innovative SAP Sovereign Cloud capabilities, which are designed to address the increasing demand from organizations for data sovereignty, robust security, and regulatory compliance. This pioneering solution enables...

Continue Reading
Corbus Pharma's Stock Drops 60%: Analysts Recommend Buying Now

Updated Category News Views 92

Corbus Pharmaceuticals Sees Significant Stock Drop Amid Market Responses Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) has recently faced a dramatic decline in its stock, plummeting by an alarming 60%. However, analysts are encouraging investors to view this as a potential buying opportunity. Firms like H.C. Wainwright and Oppenheimer have reaffirmed their buy...

Continue Reading
Manatt Welcomes New Partner with Extensive Investment Expertise

Updated Category News Views 139

Manatt's Strategic Growth in Corporate Practice Manatt, Phelps & Phillips, LLP is making waves in the corporate legal landscape with its recent addition of Peter Tsirigotis, a seasoned investment funds partner. This move reflects the firm's commitment to expanding its financial services and corporate capabilities. Based in Washington, D.C., Tsirigotis brings a wealth of...

Continue Reading
Performance Share Units Vesting: ISS A/S Updates Details

Updated Category News Views 216

Performance Share Units Vesting Announcement ISS A/S is proud to announce the significant milestone concerning its long-term incentive program (LTIP). As part of this initiative, a number of Performance Share Units (PSUs) have recently vested, leading to the delivery of ISS shares to key personnel within the company. This process, which emphasizes the company's commitment...

Continue Reading
Omnicom Boosts Dividend: New Shareholder Benefit Unveiled

Updated Category News Views 196

Omnicom Boosts Dividend for Shareholders Omnicom, a renowned leader in marketing and sales, has officially announced an increase in its quarterly dividend to $0.80 per share. This enhancement reflects a significant increase in the company's commitment to its shareholders, offering both immediate rewards and a long-term strategy for growth. Dividend Increase Overview The...

Continue Reading